BioAtla, Inc.
BCAB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $40 | $23 | $20 | $30 |
| - Cash | $8 | $18 | $32 | $49 |
| + Debt | $6 | $6 | $1 | $1 |
| Enterprise Value | $38 | $11 | -$12 | -$19 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$1 | -$0 | -$12 |
| % Margin | – | – | – | – |
| EBITDA | -$16 | -$19 | -$17 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$16 | -$19 | -$15 | -$15 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.27 | -0.32 | -0.26 | -0.3 |
| % Growth | 15.6% | -23.1% | 13.3% | – |
| Operating Cash Flow | -$10 | -$14 | -$16 | -$17 |
| Capital Expenditures | $0 | $14 | $0 | $0 |
| Free Cash Flow | -$10 | $0 | -$16 | -$17 |